Enhanced response of melanoma cells to MEK inhibitors following unbiased IGF-1R down-regulation

Due to its ability to compensate for signals lost following therapeutic MAPK-inhibition, insulin-like growth factor type 1 receptor (IGF-1R) co-targeting is a rational approach for melanoma treatment. However IGF-1R conformational changes associated with its inhibition can preferentially activate MA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Suleymanova, Naida, Crudden, Caitrin, Worrall, Claire, Dricu, Anica, Girnita, Ada, Girnita, Leonard
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5669887/
https://ncbi.nlm.nih.gov/pubmed/29137261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19286
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars